HQ Function

Previously served as the central hub for corporate operations, strategic planning, R&D oversight, and administrative functions. Post-Chapter 11, its function is minimal, related to administering the bankruptcy process with a skeleton staff.

Notable Features:

The former headquarters was situated in Silicon Valley, a key biotech hub. Specific architectural details of the leased office space are not widely publicized.

Work Culture:

Prior to restructuring, Eiger likely fostered a mission-driven culture focused on rare diseases. Currently, the work environment is centered on managing the Chapter 11 process and wind-down activities, involving a very small team of remaining employees and restructuring professionals.

HQ Significance:

Historically, the Palo Alto location was significant for its proximity to innovation, talent, and capital within the biotech industry. Its current physical significance is greatly diminished due to the company's operational wind-down.

Values Reflected in HQ: Past location choices likely reflected an ambition for innovation and scientific advancement. The current situation primarily reflects a period of financial restructuring and operational wind-down rather than value expression through physical space.

Location:

Historically, Eiger BioPharmaceuticals' global presence was characterized by its international clinical trials for rare disease therapies and the global commercialization of Zokinvy®. Following the Chapter 11 filing and the sale of its key commercial assets, its global operational activities have been significantly curtailed as the company proceeds with its wind-down plan.

Street Address:

350 Cambridge Ave, Suite 350

City:

Palo Alto

State/Province:

CA

Country:

USA